<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00999141</url>
  </required_header>
  <id_info>
    <org_study_id>550901</org_study_id>
    <nct_id>NCT00999141</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of FS VH S/D 4 S-apr for Flap Adherence in Rhytidectomy</brief_title>
  <official_title>A Randomized, Controlled Phase 3 Study to Evaluate Safety and Efficacy of Fibrin Sealant (FS) VH S/D 4 S-apr (ARTISS) to Adhere Tissues and Improve Wound Healing in Subjects Undergoing Rhytidectomy (Facelift)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baxter Healthcare Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare the safety and efficacy of FS VH S/D 4 s-apr versus
      standard of care in adhering tissue and improving wound healing in subjects undergoing
      facelift.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Volume of Drainage on Each Side of the Face</measure>
    <time_frame>24 hours (Â± 4h) after surgery</time_frame>
    <description>Total drainage volume collected from each side of the face. One side of face is treated with FS VH S/D 4 s-apr (FS); the other side is treated using standard of care (SoC).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of AEs Related to the Investigational Product (FS VH S/D 4 S-apr)</measure>
    <time_frame>Day 0 (day of surgery) through postoperative Day 14</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participants' First Occurrence of Hematoma or Seroma by Study Day</measure>
    <time_frame>Day 0 (day of surgery) through postoperative day 14</time_frame>
    <description>Investigators assessed each side of the face for the presence of hematomas and/or seromas</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants With Hematoma/Seroma by Study Day</measure>
    <time_frame>Day 0 (day of surgery) through postoperative day 14</time_frame>
    <description>Investigators assessed each side of the face for the presence of hematoma and/or seroma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Hematoma/Seroma Anytime During the Study</measure>
    <time_frame>Day 0 (day of surgery) through postoperative Day 14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigators' Visual Comparisons of Edema Between the 2 Sides of Face at Day 1</measure>
    <time_frame>Through postoperative Day 1</time_frame>
    <description>Investigators' assessed which side of the face (FS VH S/D 4 s-apr or Standard SoC) had less edema</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigators' Visual Comparisons of Edema Between the 2 Sides of Face at Day 3</measure>
    <time_frame>Through postoperative Day 3</time_frame>
    <description>Investigators' assessed which side of the face (FS VH S/D 4 s-apr or Standard SoC) had less edema</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigators' Visual Comparisons of Edema Between the 2 Sides of Face at Day 7</measure>
    <time_frame>Through postoperative Day 7</time_frame>
    <description>Investigators' assessed which side of the face (FS VH S/D 4 s-apr or Standard SoC) had less edema</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigators' Visual Comparisons of Edema Between the 2 Sides of Face at Day 14</measure>
    <time_frame>Through postoperative Day 14</time_frame>
    <description>Investigators' assessed which side of the face (FS VH S/D 4 s-apr or Standard SoC) had less edema</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline (Day 0, Preoperative) in Skin Sensitivity on Postoperative Days 3, 7, 14</measure>
    <time_frame>Day 0 (preoperative) through postoperative Day 14</time_frame>
    <description>Skin sensitivity was measured using Semmes-Weinstein Monofilament set to detect neurological damage. Filament sizes are noted by handle numbers of measuring tools ([handle number = log10(10*force in milligrams applied to skin)], range = 1.65 to 6.65). Detection of filament with smaller handle number = greater skin sensitivity. Smaller change in filament size detection from pre-op to post-op = less impact to recovery of sensation. Smallest filament felt for each side of face was noted. Change in skin sensitivity computed as (Handle Number Postop Day 3, 7, or 14) - (Handle Number Preop Day 0).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants' Assessment of Side of Face Preference (SoC and FS VH S/D 4) on Postoperative Days 1, 3, 7, 14</measure>
    <time_frame>Through postoperative Day 14</time_frame>
    <description>Participants responded to the following question during the side of face preference assessment:
&quot;Which side of the face do you prefer? Left side, right side, or no preference?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of Participants Preferring Either FS VH S/D 4 S-apr or SoC Side of Face - Day 1</measure>
    <time_frame>Through postoperative Day 1</time_frame>
    <description>Participants responded to the following question during the side of face preference assessment:
&quot;Which side of the face do you prefer? Left side, right side, or no preference?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of Participants Preferring Either FS VH S/D 4 S-apr or SoC Side of Face - Day 3</measure>
    <time_frame>Through postoperative Day 3</time_frame>
    <description>Participants responded to the following question during the side of face preference assessment:
&quot;Which side of the face do you prefer? Left side, right side, or no preference?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of Participants Preferring Either FS VH S/D 4 S-apr or SoC Side of Face - Day 7</measure>
    <time_frame>Through postoperative Day 7</time_frame>
    <description>Participants responded to the following question during the side of face preference assessment:
&quot;Which side of the face do you prefer? Left side, right side, or no preference?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of Participants Preferring Either FS VH S/D 4 S-apr or SoC Side of Face - Day 14</measure>
    <time_frame>Through postoperative Day 14</time_frame>
    <description>Participants responded to the following question during the side of face preference assessment:
&quot;Which side of the face do you prefer? Left side, right side, or no preference?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reasons for Participants' Preferences for Side of Face</measure>
    <time_frame>Through postoperative Day 14</time_frame>
    <description>Participants responded to the following questions during the side of face preference assessment:
&quot;Which side of the face do you prefer? Left side, right side, or no preference?&quot;
If &quot;right&quot; or &quot;left&quot; is chosen, participants were asked &quot;Please mark ALL reasons for choosing this side&quot;
Better skin sensation
Less numbness
Looks better
Less bruising
Less swelling
Less pain
Less itching
Less tingling
Less feeling of &quot;pins and needles&quot;
Other ________________ (Free Text)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Participants' Assessment of Difference in Numbness Between Two Sides of Face</measure>
    <time_frame>Through postoperative Day 14</time_frame>
    <description>During each postoperative visit (Day 1, 3, 7, and 14), participants were asked:
How would you rate your numbness on each side of your face on a scale of 0-10, with 10 being the worst numbness possible?
Difference in scores on a scale = (SoC score) - (FS VH S/D 4 s-apr score)
The planned and approved Statistical Analysis Plan (SAP) called for a pre-aggregation of the data whereby differences between the two sides of the face were computed first within participants to retain the inherent correlation (pairings) in the measures. Summary statistics and statistical tests were then computed on the differences between the two sides of the face using paired sample tests.</description>
  </other_outcome>
  <other_outcome>
    <measure>Investigator Preference for Side of Face</measure>
    <time_frame>Through postoperative Day 14</time_frame>
    <description>Investigator reported outcomes data was collected for overall preference for 1 side of face</description>
  </other_outcome>
  <other_outcome>
    <measure>Investigators' Satisfaction With Quality of Flap Adherence</measure>
    <time_frame>Through postoperative Day 14</time_frame>
    <description>During postoperative visits investigators recorded their satisfaction with the quality of flap adherence for each side of the face (FS VH S/D 4 s-apr (FS) or Standard of Care (SoC) sides of face)</description>
  </other_outcome>
  <other_outcome>
    <measure>Investigators' Satisfaction With Rate of Healing</measure>
    <time_frame>Through postoperative Day 14</time_frame>
    <description>During postoperative visits investigators recorded their satisfaction with the rate of healing of each side of the face (FS VH S/D 4 s-apr (FS) or Standard of Care (SoC) sides of face)</description>
  </other_outcome>
  <other_outcome>
    <measure>Investigators' Satisfaction With Treatment</measure>
    <time_frame>Through postoperative Day 14</time_frame>
    <description>During postoperative visits investigators recorded their satisfaction with treatment on each side of the face (FS VH S/D 4 s-apr (FS) or Standard of Care (SoC) sides of face)</description>
  </other_outcome>
  <other_outcome>
    <measure>Investigators' Confidence in Decreased Postsurgical Complications With the Use of FS VH S/D 4 S-apr</measure>
    <time_frame>Through postoperative Day 14</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Total Aspiration Volumes From Hematomas and Seromas</measure>
    <time_frame>Through postoperative Day 14</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Face-lift</condition>
  <condition>Facial Rhytidectomy</condition>
  <arm_group>
    <arm_group_label>FS VH S/D 4 s-apr</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One side of face will be treated with the investigational product (FS VH S/D 4 s-apr) as an adjuvant to the standard of care. Please note: Each subject will participate in both arms (investigational product and standard of care) simultaneously, and will serve as his/her own control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care (SoC)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Other side of face will receive standard of care. Please note: Each subject will participate in both arms (investigational product and standard of care) simultaneously, and will serve as his/her own control.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>FS VH S/D 4 s-apr</intervention_name>
    <description>FS VH S/D 4 s-apr will be applied (using spray device provided by Sponsor) to the subcutaneous plane (intraoperative, topical administration) in both the neck and the face area.</description>
    <arm_group_label>FS VH S/D 4 s-apr</arm_group_label>
    <other_name>ARTISS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female subject is 18 to 75 years of age at the time of screening

          -  Subject is planned for facial rhytidectomy

          -  Subject has read, understood and signed the written informed consent

          -  Subject is healthy, as determined by the investigator using standard pre-operative
             assessments to include laboratory tests and electrocardiograms

          -  Subject is of childbearing potential, presents with a negative serum pregnancy test,
             and agrees to employ adequate birth control measures for the duration of the study

          -  Subject is willing and able to comply with the requirements of the protocol

        Exclusion Criteria:

          -  Subject is indicated for an abbreviated or modified face-lift procedure such as deep
             plane procedures, minimal undermining procedures, thread lifts, and minimal access
             cranial suspension

          -  Subject is indicated for concurrent facial surgeries during the operation (eg forehead
             plasty,blepharoplasty, rhinoplasty, buccal fat removal, any filler injections
             including fat injections, lip augmentation, skin resurfacing procedures etc.)

          -  Subject is indicated for additional procedures to the body during the same operation
             (eg liposuction, mastoplasty etc.)

          -  Subject has undergone a prior rhytidectomy surgery

          -  Subject is an active smoker, as assessed by the investigator

          -  Subject has a known (documented) bleeding or coagulation disorder

          -  Subject is being treated with anti-coagulants or with Aspirin (that was not
             discontinued 7 days prior to surgery)

          -  Subject has a vascular disorder, cardiovascular disease, and/or uncontrolled
             hypertension

          -  Subject has diabetes mellitus with glycosylated hemoglobin (HbA1c) &gt; 7

          -  Subject is receiving active treatment for a malignancy

          -  Subject has a connective tissue disorder

          -  Subject has an active or chronic skin disorder

          -  Subject has history of Bell's palsy

          -  Subject has a documented history of pathologically or pharmacologically induced immune
             deficiency

          -  Subject has received chronic treatment with immunosuppressive drugs, systemic
             corticosteroids, or other chronic treatments within 30 days prior to the surgery

          -  Subject has a known sensitivity to components of FS VH S/D 4 s-apr

          -  Subject has a known psychiatric disorder (eg, obsessive compulsive disorder, anxiety,
             eating disorders, etc.)

          -  Subject has documented healing complications following previous surgeries (eg,
             hypertrophic scarring)

          -  Subject is pregnant or lactating at the time of enrollment

          -  Subject has participated in another clinical study involving an investigational
             product/device within 30 days prior to enrollment or is scheduled to participate in
             another clinical study involving an investigational product/device during the course
             of this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steve Z Abrams, MD</last_name>
    <role>Study Director</role>
    <affiliation>Baxter Healthcare Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Evans</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hewlett</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2009</study_first_submitted>
  <study_first_submitted_qc>October 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2009</study_first_posted>
  <results_first_submitted>October 6, 2011</results_first_submitted>
  <results_first_submitted_qc>August 14, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 27, 2012</results_first_posted>
  <disposition_first_submitted>December 17, 2010</disposition_first_submitted>
  <disposition_first_submitted_qc>December 17, 2010</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">December 23, 2010</disposition_first_posted>
  <last_update_submitted>October 4, 2012</last_update_submitted>
  <last_update_submitted_qc>October 4, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 8, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were enrolled at 7 clinical sites in the United States, beginning September 2009 and completing in December 2009</recruitment_details>
      <pre_assignment_details>79 participants were enrolled and screened. 2 were screen failures and 2 requested withdrawal. Therefore, 75 of the 79 enrolled were randomized.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Facelift Participants</title>
          <description>One side of face will be treated with the investigational product (FS VH S/D 4 s-apr) as an adjuvant to the standard of care (SoC), and the other side of the face will receive SoC alone. Please note: Each subject will participate in both arms (investigational product and SoC) simultaneously, and will serve as his/her own control.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="75">Randomized and treated</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Facelift Participants</title>
          <description>One side of face will be treated with the investigational product (FS VH S/D 4 s-apr) as an adjuvant to the standard of care (SoC), and the other side of the face will receive SoC alone. Please note: Each subject will participate in both arms (investigational product and SoC) simultaneously, and will serve as his/her own control.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="75"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.4" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Volume of Drainage on Each Side of the Face</title>
        <description>Total drainage volume collected from each side of the face. One side of face is treated with FS VH S/D 4 s-apr (FS); the other side is treated using standard of care (SoC).</description>
        <time_frame>24 hours (Â± 4h) after surgery</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care (SoC)</title>
          </group>
          <group group_id="O2">
            <title>FS VH S/D 4 S-apr</title>
          </group>
        </group_list>
        <measure>
          <title>Total Volume of Drainage on Each Side of the Face</title>
          <description>Total drainage volume collected from each side of the face. One side of face is treated with FS VH S/D 4 s-apr (FS); the other side is treated using standard of care (SoC).</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>mL</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.0" lower_limit="0" upper_limit="50"/>
                    <measurement group_id="O2" value="8.0" lower_limit="0" upper_limit="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>two-sided paired t-test</method>
            <method_desc>alpha = 5%</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Participants' First Occurrence of Hematoma or Seroma by Study Day</title>
        <description>Investigators assessed each side of the face for the presence of hematomas and/or seromas</description>
        <time_frame>Day 0 (day of surgery) through postoperative day 14</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>FS VH S/D 4 S-apr Side - Hematoma</title>
          </group>
          <group group_id="O2">
            <title>FS VH S/D 4 S-apr Side - Seroma</title>
          </group>
          <group group_id="O3">
            <title>Standard of Care (SoC) Side - Hematoma</title>
          </group>
          <group group_id="O4">
            <title>Standard of Care (SoC) Side - Seroma</title>
          </group>
        </group_list>
        <measure>
          <title>Participants' First Occurrence of Hematoma or Seroma by Study Day</title>
          <description>Investigators assessed each side of the face for the presence of hematomas and/or seromas</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 11</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 13</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Participants With Hematoma/Seroma by Study Day</title>
        <description>Investigators assessed each side of the face for the presence of hematoma and/or seroma</description>
        <time_frame>Day 0 (day of surgery) through postoperative day 14</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>FS VH S/D 4 S-apr</title>
            <description>Participants With Hematoma/Seroma on FS VH S/D 4 s-apr Side</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care (SoC)</title>
            <description>Participants With Hematoma/Seroma on SoC Side</description>
          </group>
        </group_list>
        <measure>
          <title>Participants With Hematoma/Seroma by Study Day</title>
          <description>Investigators assessed each side of the face for the presence of hematoma and/or seroma</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 11</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 13</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Hematoma/Seroma Anytime During the Study</title>
        <time_frame>Day 0 (day of surgery) through postoperative Day 14</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Participants With Hematoma/Seroma on FS VH S/D 4 S-apr Side</title>
          </group>
          <group group_id="O2">
            <title>Participants With Hematoma/Seroma on SoC Side</title>
          </group>
          <group group_id="O3">
            <title>Participants With Hematoma/Seroma on Both Sides</title>
          </group>
          <group group_id="O4">
            <title>Participants With No Hematoma/Seroma on Either Side</title>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Hematoma/Seroma Anytime During the Study</title>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.257</p_value>
            <method>McNemar</method>
            <method_desc>alpha = 5%</method_desc>
            <param_type>Difference in Proportions</param_type>
            <param_value>0.040</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-0.039</ci_lower_limit>
            <ci_upper_limit>0.125</ci_upper_limit>
            <estimate_desc>Difference in Proportions = (SoC) - (FS VH S/D 4 s-apr)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Investigatorsâ Visual Comparisons of Edema Between the 2 Sides of Face at Day 1</title>
        <description>Investigatorsâ assessed which side of the face (FS VH S/D 4 s-apr or Standard SoC) had less edema</description>
        <time_frame>Through postoperative Day 1</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Participants With Less Edema on FS VH S/D 4 S-apr Side</title>
          </group>
          <group group_id="O2">
            <title>Participants With Less Edema on SoC Side</title>
          </group>
          <group group_id="O3">
            <title>Participants With No Difference in Edema</title>
          </group>
        </group_list>
        <measure>
          <title>Investigatorsâ Visual Comparisons of Edema Between the 2 Sides of Face at Day 1</title>
          <description>Investigatorsâ assessed which side of the face (FS VH S/D 4 s-apr or Standard SoC) had less edema</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
                <count group_id="O3" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>McNemar</method>
            <method_desc>alpha = 5%</method_desc>
            <param_type>Difference in proportions</param_type>
            <param_value>-0.373</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-0.524</ci_lower_limit>
            <ci_upper_limit>-0.193</ci_upper_limit>
            <estimate_desc>Difference in proportions = SoC - FS VH S/D 4 s-apr</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Investigators' Visual Comparisons of Edema Between the 2 Sides of Face at Day 3</title>
        <description>Investigators' assessed which side of the face (FS VH S/D 4 s-apr or Standard SoC) had less edema</description>
        <time_frame>Through postoperative Day 3</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Participants With Less Edema on FS VH S/D 4 S-apr Side</title>
          </group>
          <group group_id="O2">
            <title>Participants With Less Edema on SoC Side</title>
          </group>
          <group group_id="O3">
            <title>Participants With No Difference in Edema</title>
          </group>
        </group_list>
        <measure>
          <title>Investigators' Visual Comparisons of Edema Between the 2 Sides of Face at Day 3</title>
          <description>Investigators' assessed which side of the face (FS VH S/D 4 s-apr or Standard SoC) had less edema</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
                <count group_id="O3" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>McNemar</method>
            <param_type>Difference in proportions</param_type>
            <param_value>-0.387</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-0.538</ci_lower_limit>
            <ci_upper_limit>-0.205</ci_upper_limit>
            <estimate_desc>Difference in Proportions = SoC - FS VH S/D 4 s-apr</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Investigators' Visual Comparisons of Edema Between the 2 Sides of Face at Day 7</title>
        <description>Investigators' assessed which side of the face (FS VH S/D 4 s-apr or Standard SoC) had less edema</description>
        <time_frame>Through postoperative Day 7</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Participants With Less Edema on FS VH S/D 4 S-apr Side</title>
          </group>
          <group group_id="O2">
            <title>Participants With Less Edema on SoC Side</title>
          </group>
          <group group_id="O3">
            <title>Participants With No Difference in Edema</title>
          </group>
        </group_list>
        <measure>
          <title>Investigators' Visual Comparisons of Edema Between the 2 Sides of Face at Day 7</title>
          <description>Investigators' assessed which side of the face (FS VH S/D 4 s-apr or Standard SoC) had less edema</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
                <count group_id="O2" value="73"/>
                <count group_id="O3" value="73"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>McNemar</method>
            <method_desc>alpha = 5%</method_desc>
            <param_type>Difference in proportions</param_type>
            <param_value>-0.356</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-0.521</ci_lower_limit>
            <ci_upper_limit>-0.161</ci_upper_limit>
            <estimate_desc>Difference in proportions = SoC - FS VH S/D 4 s-apr</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Investigators' Visual Comparisons of Edema Between the 2 Sides of Face at Day 14</title>
        <description>Investigators' assessed which side of the face (FS VH S/D 4 s-apr or Standard SoC) had less edema</description>
        <time_frame>Through postoperative Day 14</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Participants With Less Edema on FS VH S/D 4 S-apr Side</title>
          </group>
          <group group_id="O2">
            <title>Participants With Less Edema on SoC Side</title>
          </group>
          <group group_id="O3">
            <title>Participants With No Difference in Edema</title>
          </group>
        </group_list>
        <measure>
          <title>Investigators' Visual Comparisons of Edema Between the 2 Sides of Face at Day 14</title>
          <description>Investigators' assessed which side of the face (FS VH S/D 4 s-apr or Standard SoC) had less edema</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.027</p_value>
            <method>McNemar</method>
            <method_desc>alpha = 5%</method_desc>
            <param_type>Difference in proportions</param_type>
            <param_value>-0.189</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-0.342</ci_lower_limit>
            <ci_upper_limit>-0.023</ci_upper_limit>
            <estimate_desc>Difference in proportions = SoC - FS VH S/D 4 s-apr</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline (Day 0, Preoperative) in Skin Sensitivity on Postoperative Days 3, 7, 14</title>
        <description>Skin sensitivity was measured using Semmes-Weinstein Monofilament set to detect neurological damage. Filament sizes are noted by handle numbers of measuring tools ([handle number = log10(10*force in milligrams applied to skin)], range = 1.65 to 6.65). Detection of filament with smaller handle number = greater skin sensitivity. Smaller change in filament size detection from pre-op to post-op = less impact to recovery of sensation. Smallest filament felt for each side of face was noted. Change in skin sensitivity computed as (Handle Number Postop Day 3, 7, or 14) - (Handle Number Preop Day 0).</description>
        <time_frame>Day 0 (preoperative) through postoperative Day 14</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>FS VH S/D 4 S-apr</title>
          </group>
          <group group_id="O2">
            <title>Standard of Care (SoC)</title>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline (Day 0, Preoperative) in Skin Sensitivity on Postoperative Days 3, 7, 14</title>
          <description>Skin sensitivity was measured using Semmes-Weinstein Monofilament set to detect neurological damage. Filament sizes are noted by handle numbers of measuring tools ([handle number = log10(10*force in milligrams applied to skin)], range = 1.65 to 6.65). Detection of filament with smaller handle number = greater skin sensitivity. Smaller change in filament size detection from pre-op to post-op = less impact to recovery of sensation. Smallest filament felt for each side of face was noted. Change in skin sensitivity computed as (Handle Number Postop Day 3, 7, or 14) - (Handle Number Preop Day 0).</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>Handle number(s)</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.54" spread="0.85" lower_limit="0.34" upper_limit="0.73"/>
                    <measurement group_id="O2" value="0.60" spread="0.94" lower_limit="0.39" upper_limit="0.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.44" spread="0.94" lower_limit="0.22" upper_limit="0.65"/>
                    <measurement group_id="O2" value="0.51" spread="1.02" lower_limit="0.27" upper_limit="0.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.82" lower_limit="0.05" upper_limit="0.42"/>
                    <measurement group_id="O2" value="0.32" spread="0.96" lower_limit="0.10" upper_limit="0.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Participants' Assessment of Side of Face Preference (SoC and FS VH S/D 4) on Postoperative Days 1, 3, 7, 14</title>
        <description>Participants responded to the following question during the side of face preference assessment:
âWhich side of the face do you prefer? Left side, right side, or no preference?â</description>
        <time_frame>Through postoperative Day 14</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Participants Preferring FS VH S/D 4 S-apr</title>
          </group>
          <group group_id="O2">
            <title>Participants Preferring SoC</title>
          </group>
          <group group_id="O3">
            <title>Participants With No Preference</title>
          </group>
        </group_list>
        <measure>
          <title>Participants' Assessment of Side of Face Preference (SoC and FS VH S/D 4) on Postoperative Days 1, 3, 7, 14</title>
          <description>Participants responded to the following question during the side of face preference assessment:
âWhich side of the face do you prefer? Left side, right side, or no preference?â</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
                <count group_id="O3" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1 (n= 75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3 (n= 75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7 (n= 75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (n= 74)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Proportion of Participants Preferring Either FS VH S/D 4 S-apr or SoC Side of Face - Day 1</title>
        <description>Participants responded to the following question during the side of face preference assessment:
âWhich side of the face do you prefer? Left side, right side, or no preference?â</description>
        <time_frame>Through postoperative Day 1</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Proportion of Participants Preferring FS VH S/D 4 S-apr Side</title>
          </group>
          <group group_id="O2">
            <title>Proportion of Participants Preferring SoC Side</title>
          </group>
        </group_list>
        <measure>
          <title>Proportion of Participants Preferring Either FS VH S/D 4 S-apr or SoC Side of Face - Day 1</title>
          <description>Participants responded to the following question during the side of face preference assessment:
âWhich side of the face do you prefer? Left side, right side, or no preference?â</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>Proportion of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.63"/>
                    <measurement group_id="O2" value="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Difference in Proportions</param_type>
            <param_value>-0.413</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-0.577</ci_lower_limit>
            <ci_upper_limit>-0.213</ci_upper_limit>
            <estimate_desc>Difference in Proportions = (SoC) - (FS VH S/D 4 s-apr)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Proportion of Participants Preferring Either FS VH S/D 4 S-apr or SoC Side of Face - Day 3</title>
        <description>Participants responded to the following question during the side of face preference assessment:
âWhich side of the face do you prefer? Left side, right side, or no preference?â</description>
        <time_frame>Through postoperative Day 3</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Proportion of Participants Preferring FS VH S/D 4 S-apr Side</title>
          </group>
          <group group_id="O2">
            <title>Proportion of Participants Preferring SoC Side</title>
          </group>
        </group_list>
        <measure>
          <title>Proportion of Participants Preferring Either FS VH S/D 4 S-apr or SoC Side of Face - Day 3</title>
          <description>Participants responded to the following question during the side of face preference assessment:
âWhich side of the face do you prefer? Left side, right side, or no preference?â</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>Proportion of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.53"/>
                    <measurement group_id="O2" value="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Difference in Proportions</param_type>
            <param_value>-0.227</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-0.413</ci_lower_limit>
            <ci_upper_limit>-0.020</ci_upper_limit>
            <estimate_desc>Difference in Proportions = (SoC) - (FS VH S/D 4 s-apr)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Proportion of Participants Preferring Either FS VH S/D 4 S-apr or SoC Side of Face - Day 7</title>
        <description>Participants responded to the following question during the side of face preference assessment:
âWhich side of the face do you prefer? Left side, right side, or no preference?â</description>
        <time_frame>Through postoperative Day 7</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Proportion of Participants Preferring FS VH S/D 4 S-apr Side</title>
          </group>
          <group group_id="O2">
            <title>Proportion of Participants Preferring SoC Side</title>
          </group>
        </group_list>
        <measure>
          <title>Proportion of Participants Preferring Either FS VH S/D 4 S-apr or SoC Side of Face - Day 7</title>
          <description>Participants responded to the following question during the side of face preference assessment:
âWhich side of the face do you prefer? Left side, right side, or no preference?â</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>Proportion of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.59"/>
                    <measurement group_id="O2" value="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Difference in Proportions</param_type>
            <param_value>-0.347</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-0.518</ci_lower_limit>
            <ci_upper_limit>-0.145</ci_upper_limit>
            <estimate_desc>Difference in Proportions = (SoC) - (FS VH S/D 4 s-apr)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Proportion of Participants Preferring Either FS VH S/D 4 S-apr or SoC Side of Face - Day 14</title>
        <description>Participants responded to the following question during the side of face preference assessment:
âWhich side of the face do you prefer? Left side, right side, or no preference?â</description>
        <time_frame>Through postoperative Day 14</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Proportion of Participants Preferring FS VH S/D 4 S-apr Side</title>
          </group>
          <group group_id="O2">
            <title>Proportion of Participants Preferring SoC Side</title>
          </group>
        </group_list>
        <measure>
          <title>Proportion of Participants Preferring Either FS VH S/D 4 S-apr or SoC Side of Face - Day 14</title>
          <description>Participants responded to the following question during the side of face preference assessment:
âWhich side of the face do you prefer? Left side, right side, or no preference?â</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>Proportion of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.57"/>
                    <measurement group_id="O2" value="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Difference in Proportions</param_type>
            <param_value>-0.365</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-0.528</ci_lower_limit>
            <ci_upper_limit>-0.171</ci_upper_limit>
            <estimate_desc>Difference in Proportions = (SoC) - (FS VH S/D 4 s-apr)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Reasons for Participantsâ Preferences for Side of Face</title>
        <description>Participants responded to the following questions during the side of face preference assessment:
&quot;Which side of the face do you prefer? Left side, right side, or no preference?&quot;
If &quot;right&quot; or &quot;left&quot; is chosen, participants were asked &quot;Please mark ALL reasons for choosing this side&quot;
Better skin sensation
Less numbness
Looks better
Less bruising
Less swelling
Less pain
Less itching
Less tingling
Less feeling of &quot;pins and needles&quot;
Other ________________ (Free Text)</description>
        <time_frame>Through postoperative Day 14</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>FS VH S/D 4 S-apr Side - Day 1</title>
          </group>
          <group group_id="O2">
            <title>SoC Side - Day 1</title>
          </group>
          <group group_id="O3">
            <title>FS VH S/D 4 S-apr Side - Day 3</title>
          </group>
          <group group_id="O4">
            <title>SoC Side - Day 3</title>
          </group>
          <group group_id="O5">
            <title>FS VH S/D 4 S-apr Side - Day 7</title>
          </group>
          <group group_id="O6">
            <title>SoC Side - Day 7</title>
          </group>
          <group group_id="O7">
            <title>FS VH S/D 4 S-apr Side - Day 14</title>
          </group>
          <group group_id="O8">
            <title>SoC Side - Day 14</title>
          </group>
        </group_list>
        <measure>
          <title>Reasons for Participantsâ Preferences for Side of Face</title>
          <description>Participants responded to the following questions during the side of face preference assessment:
&quot;Which side of the face do you prefer? Left side, right side, or no preference?&quot;
If &quot;right&quot; or &quot;left&quot; is chosen, participants were asked &quot;Please mark ALL reasons for choosing this side&quot;
Better skin sensation
Less numbness
Looks better
Less bruising
Less swelling
Less pain
Less itching
Less tingling
Less feeling of &quot;pins and needles&quot;
Other ________________ (Free Text)</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="23"/>
                <count group_id="O5" value="44"/>
                <count group_id="O6" value="18"/>
                <count group_id="O7" value="42"/>
                <count group_id="O8" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Better Skin Sensation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="19"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="26"/>
                    <measurement group_id="O8" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Less Bruising</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="21"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="30"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="29"/>
                    <measurement group_id="O8" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Less Feeling of Pins and Needles</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Less Itching</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Less Numbness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="24"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="28"/>
                    <measurement group_id="O8" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Less Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="26"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="25"/>
                    <measurement group_id="O8" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Less Swelling</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="30"/>
                    <measurement group_id="O4" value="16"/>
                    <measurement group_id="O5" value="33"/>
                    <measurement group_id="O6" value="14"/>
                    <measurement group_id="O7" value="36"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Less Tingling</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="9"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="16"/>
                    <measurement group_id="O8" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Looks Better</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="32"/>
                    <measurement group_id="O4" value="19"/>
                    <measurement group_id="O5" value="37"/>
                    <measurement group_id="O6" value="13"/>
                    <measurement group_id="O7" value="35"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Participants' Assessment of Difference in Numbness Between Two Sides of Face</title>
        <description>During each postoperative visit (Day 1, 3, 7, and 14), participants were asked:
How would you rate your numbness on each side of your face on a scale of 0-10, with 10 being the worst numbness possible?
Difference in scores on a scale = (SoC score) - (FS VH S/D 4 s-apr score)
The planned and approved Statistical Analysis Plan (SAP) called for a pre-aggregation of the data whereby differences between the two sides of the face were computed first within participants to retain the inherent correlation (pairings) in the measures. Summary statistics and statistical tests were then computed on the differences between the two sides of the face using paired sample tests.</description>
        <time_frame>Through postoperative Day 14</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Facelift Participants</title>
          </group>
        </group_list>
        <measure>
          <title>Participants' Assessment of Difference in Numbness Between Two Sides of Face</title>
          <description>During each postoperative visit (Day 1, 3, 7, and 14), participants were asked:
How would you rate your numbness on each side of your face on a scale of 0-10, with 10 being the worst numbness possible?
Difference in scores on a scale = (SoC score) - (FS VH S/D 4 s-apr score)
The planned and approved Statistical Analysis Plan (SAP) called for a pre-aggregation of the data whereby differences between the two sides of the face were computed first within participants to retain the inherent correlation (pairings) in the measures. Summary statistics and statistical tests were then computed on the differences between the two sides of the face using paired sample tests.</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>Scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Postoperative Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Investigator Preference for Side of Face</title>
        <description>Investigator reported outcomes data was collected for overall preference for 1 side of face</description>
        <time_frame>Through postoperative Day 14</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Strongly Prefer FS VH S/D 4 S-apr Side</title>
          </group>
          <group group_id="O2">
            <title>Somewhat Prefer FS VH S/D 4 S-apr Side</title>
          </group>
          <group group_id="O3">
            <title>No Preference</title>
          </group>
          <group group_id="O4">
            <title>Somewhat Prefer SoC Side</title>
          </group>
          <group group_id="O5">
            <title>Strongly Prefer SoC Side</title>
          </group>
        </group_list>
        <measure>
          <title>Investigator Preference for Side of Face</title>
          <description>Investigator reported outcomes data was collected for overall preference for 1 side of face</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="75"/>
                <count group_id="O5" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Postoperative Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="33"/>
                    <measurement group_id="O3" value="21"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="37"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="31"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Postoperative Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="25"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Investigators' Satisfaction With Quality of Flap Adherence</title>
        <description>During postoperative visits investigators recorded their satisfaction with the quality of flap adherence for each side of the face (FS VH S/D 4 s-apr (FS) or Standard of Care (SoC) sides of face)</description>
        <time_frame>Through postoperative Day 14</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Not at All Satisfied</title>
          </group>
          <group group_id="O2">
            <title>A Little Satisfied</title>
          </group>
          <group group_id="O3">
            <title>Somewhat Satisfied</title>
          </group>
          <group group_id="O4">
            <title>Moderately Satisfied</title>
          </group>
          <group group_id="O5">
            <title>Very Satisfied</title>
          </group>
        </group_list>
        <measure>
          <title>Investigators' Satisfaction With Quality of Flap Adherence</title>
          <description>During postoperative visits investigators recorded their satisfaction with the quality of flap adherence for each side of the face (FS VH S/D 4 s-apr (FS) or Standard of Care (SoC) sides of face)</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="75"/>
                <count group_id="O5" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Satisfaction with flap adherence FS Side- Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="19"/>
                    <measurement group_id="O5" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with flap adherence FS Side- Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="18"/>
                    <measurement group_id="O5" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with flap adherence FS Side- Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with flap adherence FS Side- Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with flap adherence SoC Side- Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="26"/>
                    <measurement group_id="O5" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with flap adherence SoC Side- Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with flap adherence SoC Side- Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="25"/>
                    <measurement group_id="O5" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with flap adherence SoC Side- Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="21"/>
                    <measurement group_id="O5" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Investigators' Satisfaction With Rate of Healing</title>
        <description>During postoperative visits investigators recorded their satisfaction with the rate of healing of each side of the face (FS VH S/D 4 s-apr (FS) or Standard of Care (SoC) sides of face)</description>
        <time_frame>Through postoperative Day 14</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Not at All Satisfied</title>
          </group>
          <group group_id="O2">
            <title>A Little Satisfied</title>
          </group>
          <group group_id="O3">
            <title>Somewhat Satisfied</title>
          </group>
          <group group_id="O4">
            <title>Moderately Satisfied</title>
          </group>
          <group group_id="O5">
            <title>Very Satisfied</title>
          </group>
        </group_list>
        <measure>
          <title>Investigators' Satisfaction With Rate of Healing</title>
          <description>During postoperative visits investigators recorded their satisfaction with the rate of healing of each side of the face (FS VH S/D 4 s-apr (FS) or Standard of Care (SoC) sides of face)</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="75"/>
                <count group_id="O5" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Satisfaction with Rate of Healing FS Side- Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="28"/>
                    <measurement group_id="O5" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Rate of Healing FS Side- Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="19"/>
                    <measurement group_id="O5" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Rate of Healing FS Side- Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Rate of Healing FS Side- Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Rate of Healing SoC Side- Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="21"/>
                    <measurement group_id="O5" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Rate of Healing SoC Side- Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="17"/>
                    <measurement group_id="O5" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Rate of Healing SoC Side- Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="24"/>
                    <measurement group_id="O5" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Rate of Healing SoC Side- Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="20"/>
                    <measurement group_id="O5" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Investigators' Satisfaction With Treatment</title>
        <description>During postoperative visits investigators recorded their satisfaction with treatment on each side of the face (FS VH S/D 4 s-apr (FS) or Standard of Care (SoC) sides of face)</description>
        <time_frame>Through postoperative Day 14</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Not at All Satisfied</title>
          </group>
          <group group_id="O2">
            <title>A Little Satisfied</title>
          </group>
          <group group_id="O3">
            <title>Somewhat Satisfied</title>
          </group>
          <group group_id="O4">
            <title>Moderately Satisfied</title>
          </group>
          <group group_id="O5">
            <title>Very Satisfied</title>
          </group>
        </group_list>
        <measure>
          <title>Investigators' Satisfaction With Treatment</title>
          <description>During postoperative visits investigators recorded their satisfaction with treatment on each side of the face (FS VH S/D 4 s-apr (FS) or Standard of Care (SoC) sides of face)</description>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="75"/>
                <count group_id="O5" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Satisfaction with Treatment on FS Side- Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="19"/>
                    <measurement group_id="O5" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Treatment on FS Side- Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Treatment on FS Side- Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Treatment on FS Side- Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Treatment on SoC Side- Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="17"/>
                    <measurement group_id="O5" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Treatment on SoC Side- Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="16"/>
                    <measurement group_id="O5" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Treatment on SoC Side- Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="19"/>
                    <measurement group_id="O5" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with Treatment on SoC Side- Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="19"/>
                    <measurement group_id="O5" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Investigatorsâ Confidence in Decreased Postsurgical Complications With the Use of FS VH S/D 4 S-apr</title>
        <time_frame>Through postoperative Day 14</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Not Confident</title>
          </group>
          <group group_id="O2">
            <title>Not Very Confident</title>
          </group>
          <group group_id="O3">
            <title>Neutral</title>
          </group>
          <group group_id="O4">
            <title>Somewhat Confident</title>
          </group>
          <group group_id="O5">
            <title>Confident</title>
          </group>
        </group_list>
        <measure>
          <title>Investigatorsâ Confidence in Decreased Postsurgical Complications With the Use of FS VH S/D 4 S-apr</title>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
                <count group_id="O3" value="75"/>
                <count group_id="O4" value="75"/>
                <count group_id="O5" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="20"/>
                    <measurement group_id="O5" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="26"/>
                    <measurement group_id="O5" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="20"/>
                    <measurement group_id="O5" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Total Aspiration Volumes From Hematomas and Seromas</title>
        <time_frame>Through postoperative Day 14</time_frame>
        <population>Full Analysis Data Set = All randomized and treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>FS VH S/D 4 S-apr Side - Hematoma</title>
          </group>
          <group group_id="O2">
            <title>SoC Side - Hematoma</title>
          </group>
          <group group_id="O3">
            <title>FS VH S/D 4 S-apr Side - Seroma</title>
          </group>
          <group group_id="O4">
            <title>SoC Side - Seroma</title>
          </group>
        </group_list>
        <measure>
          <title>Total Aspiration Volumes From Hematomas and Seromas</title>
          <population>Full Analysis Data Set = All randomized and treated participants</population>
          <units>mL</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="1.0" upper_limit="1.0">The median is the central value of a series of numbers. This arm has a single data point, i.e. no series of numbers from which to determine a central value.</measurement>
                    <measurement group_id="O2" value="4.1" lower_limit="2.5" upper_limit="8.0"/>
                    <measurement group_id="O3" value="4.7" lower_limit="3.0" upper_limit="12.5"/>
                    <measurement group_id="O4" value="7.0" lower_limit="4.7" upper_limit="16.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of AEs Related to the Investigational Product (FS VH S/D 4 S-apr)</title>
        <time_frame>Day 0 (day of surgery) through postoperative Day 14</time_frame>
        <population>Safety Analysis Set</population>
        <group_list>
          <group group_id="O1">
            <title>Related Non-Facial Adverse Events</title>
          </group>
          <group group_id="O2">
            <title>Related Facial Adverse Events</title>
          </group>
        </group_list>
        <measure>
          <title>Number of AEs Related to the Investigational Product (FS VH S/D 4 S-apr)</title>
          <population>Safety Analysis Set</population>
          <units>Events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Serious Adverse Events- Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serious Adverse Events- Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serious Adverse Events- Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>non-Serious Adverse Events- Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>non-Serious Adverse Events- Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>non-Serious Adverse Events- Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Day 0 (day of surgery) through postoperative Day 14</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Localized to SoC Side of Face</title>
          <description>AE was localized to the side of the face which was treated with standard of care (SoC).</description>
        </group>
        <group group_id="E2">
          <title>Localized to FS VH S/D 4 S-apr Side of Face</title>
          <description>AE was localized to the side of the face which was treated with FS VH S/D 4 s-apr</description>
        </group>
        <group group_id="E3">
          <title>Non-localized AEs</title>
          <description>AE affected a site other than either side of the face (ie, non-localized AE)</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (Unspecified)</default_vocab>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="75"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Wound abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="75"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (Unspecified)</default_vocab>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="75"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="75"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="75"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="75"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="75"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Baxterâs agreements with PIs may vary per requirements of the individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 1 year after study completion. Baxter requires a review of results communications (e.g., for confidential information) â¥90 days prior to submission or communication. Baxter may request an additional delay of â¤60 days (e.g., for intellectual property protection)</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery</name_or_title>
      <organization>Baxter Innovations, GmbH</organization>
      <email>edith_hantak@baxter.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

